Pharmafile Logo

Fishawack Health deepens key capabilities and builds an integrated delivery model under new Chief Marketing and Creative Officer

Polymath marketer Ryan Mason leads the newly expanded group, and Jeffrey D. Erb has been tapped to grow the media and analytics team as Chief Media Officer.

WASHINGTON, DC, May 31, 2023—Leading global commercialization partner Fishawack Health (FH) announces the integration of key capabilities within its Marketing division to seamlessly deliver connected customer experiences built on data-driven insights. Tenured agency executive Ryan Mason has been promoted to Chief Marketing and Creative Officer and will unite creative, brand, and engagement strategy and media and analytics teams.

As part of this integrated offering, FH has selected industry veteran Jeffrey D. Erb to serve as Chief Media Officer. Erb is charged with growing the company’s media and analytics capabilities to expand specialized tools and resources in house.

“Ryan’s ability to foster and build teams across creative, brand, and engagement strategy and media and analytics disciplines makes him the perfect leader as we continue to offer stakeholder-centric and integrated solutions, seamlessly connecting strategy with execution,” said Mario Muredda, President, Marketing. “Jeff’s deep expertise in advancing media and analytics capabilities is core to helping our clients deliver personalized experiences that increase awareness, shift beliefs and behaviors, and are optimized in real time.”

Both Mason and Erb will collaborate with Chief Strategy Officer Drew Desjardins and Chief Technology Officer Geoff Thorne to provide unified subject matter experts embedded within client accounts and create seamless customer experiences across all touchpoints.

“Fishawack Health has a desire to create an environment where the entrepreneurial spirit fosters inventive and innovative programs with the scale, maturity, and capabilities of a large agency,” said Mason. “Taking on this role is a precious opportunity because it will enable us to not only implement sustainable change within the agency but also, more importantly, to deliver a unified service offering that will benefit our clients and their customers. What’s thrilling about this new integrated model that we’re building is the collection of talent with the readiness and interest within the culture that exists. These don’t often align in other companies, but we are able to do this and do it well.”

Originally trained in graphic design and economics, Mason has the unusual distinction of having held the roles of Chief Creative Officer, Chief Strategy Officer, and Chief Digital Officer. The throughline in these roles has been a pursuit to develop marketing experiences that are highly relevant, strategically sound, meaningfully motivating, and rooted in deep empathy. A testament to Mason’s abilities includes a patient engagement rare disease campaign that was recognized with a prestigious Cannes Pharma Lion award in 2021.

Erb has a track record of driving transformational change within the pharmaceutical media industry and building dynamic, culture-rich teams responsible for the development and deployment of targeted and optimized campaigns. Erb is a recognized thought leader in the healthcare industry and is the recipient of numerous industry awards, including induction into the DTC Hall of Fame by DTC Perspectives and being named to MM+M’s Health Influencer 50 list.

The integration of capabilities under the Marketing umbrella is purposeful. According to Muredda, “Our unified model enables us to tap into data and deep customer insights to develop highly relevant, content-rich experiences. Medical, strategy, creative, and media work seamlessly together to maximize the relevance of a brand and to accelerate growth for our clients.”

Mason is based in Chicago and Erb is in Philadelphia. In addition to leading Marketing colleagues, they will also collaborate with FH’s community of experts in Medical; Digital Experience Technology; Policy, Value, Evidence and Access; and Consulting across 19 global hubs.

Partnering with biopharmaceutical, medical technology, and wellness clients, Mason and Erb are excited to lead interdisciplinary teams, simplifying the complex to find meaning in the science, taking a customer-centric approach to ensure that as many patients as possible benefit from scientific breakthroughs.

About Fishawack Health
Established in 2001, Fishawack Health is a purposefully built commercialization partner for the biopharmaceutical, medical technology and wellness industries. Our 1,500+ experts combine their knowledge and expertise across our core disciplines—Medical; Marketing; Digital Experience Technology; Policy, Value, Evidence and Access; and Consulting—to create the connections that make better health happen. We partner with our clients to navigate the complex and rapidly changing healthcare ecosystem. Together, we realize the potential of strategies and solutions to bring innovation to the hands of those who can benefit from it. Visit us at www.fishawack.com and follow us on Twitter and LinkedIn.

CONTACT INFORMATION

Marita Gomez marita.gomez@fishawack.com

Lizzie Mitchell elizabeth.mitchell@fishawack.com

This content was provided by Avalere Health

Company Details

 Latest Content from  Avalere Health 

Avalere Health appoints new President of Medical to lead a tech-enabled future of medical affairs

Avalere Health appoints seasoned industry executive Effie Baoutis as President of Medical.

Fishawack Health becomes Avalere Health, uncovering the potential in every product and the possibilities for every patient

As a single united organization, the company seamlessly connects science and creativity, technology and data, and ability and agility to ensure patients receive life-changing innovations faster.

Industry leader Amar Urhekar joins Fishawack Health as Chief Operating Officer to integrate interdisciplinary teams across capabilities

As Chief Operating Officer, Amar will unite global teams to drive innovation, enhance client solutions, and accelerate growth.

Fishawack Health appoints Chief People Officer to spearhead integration of talent and culture across geographies

Fishawack Health welcomes Harriet Shurville to the team as Chief People Officer to spearhead integration efforts, champion diversity and inclusion, and cultivate an environment where interdisciplinary teams thrive.

Archetypes: Rethinking go-to-market expectations to drive commercial success

In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...

Fishawack Health deepens key capabilities and builds an integrated delivery model under new Chief Marketing and Creative Officer

Polymath marketer Ryan Mason leads the newly expanded group, and Jeffrey D. Erb has been tapped to grow the media and analytics team as Chief Media Officer.

Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment

Despite significant innovation in the oncology landscape, there is a growing care gap preventing patients accessing and benefiting from innovations in cancer treatment. In this new publication, our oncology experts...

The challenges of reimbursement and innovative pricing for cell and gene therapies

Our policy and market access experts at Avalere, part of Fishawack Health, share insights on the reimbursement challenges for cell and gene therapies and discuss the challenges and opportunities of...

Digital therapeutics as a combination therapy: Maximizing asset value and therapeutic outcomes

Digital therapeutics can increase the value of medicinal assets, driving differentiation and improving outcomes for patients. But are manufacturers prepared to capitalize on this significant untapped opportunity before the tech...

Fishawack Health welcomes Mario Muredda as its new President of Marketing

Fishawack Health (FH) ushers in a new era of data-driven omnichannel marketing with the hire of healthcare marketing veteran Mario Muredda.